nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—endothelium—atherosclerosis	0.0697	0.292	CbGeAlD
Framycetin—CXCR4—blood vessel—atherosclerosis	0.0642	0.269	CbGeAlD
Framycetin—CXCR4—connective tissue—atherosclerosis	0.0329	0.138	CbGeAlD
Framycetin—CXCR4—cardiovascular system—atherosclerosis	0.0287	0.12	CbGeAlD
Framycetin—CXCR4—adipose tissue—atherosclerosis	0.0253	0.106	CbGeAlD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL4—atherosclerosis	0.0204	0.0312	CbGpPWpGaD
Framycetin—CXCR4—liver—atherosclerosis	0.0177	0.0743	CbGeAlD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CX3CR1—atherosclerosis	0.0175	0.0266	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CX3CL1—atherosclerosis	0.0171	0.0261	CbGpPWpGaD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—PLG—atherosclerosis	0.0164	0.025	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—PDGFB—atherosclerosis	0.0148	0.0225	CbGpPWpGaD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—CCL5—atherosclerosis	0.0141	0.0216	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—CX3CR1—atherosclerosis	0.014	0.0213	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL3—atherosclerosis	0.014	0.0213	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCR2—atherosclerosis	0.0126	0.0193	CbGpPWpGaD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—F2—atherosclerosis	0.0109	0.0167	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—CCR2—atherosclerosis	0.0101	0.0154	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—EDNRA—atherosclerosis	0.0101	0.0154	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—IGF2—atherosclerosis	0.00996	0.0152	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL5—atherosclerosis	0.00904	0.0138	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—AGTR1—atherosclerosis	0.00859	0.0131	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	0.00847	0.0129	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—HRH1—atherosclerosis	0.00833	0.0127	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	0.00798	0.0122	CbGpPWpGaD
Framycetin—Glaucoma—Niacin—atherosclerosis	0.00792	0.0749	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL4—atherosclerosis	0.00769	0.0117	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—VEGFA—atherosclerosis	0.00762	0.0116	CbGpPWpGaD
Framycetin—Viral infection—Ezetimibe—atherosclerosis	0.00754	0.0713	CcSEcCtD
Framycetin—CXCR4—S1P3 pathway—MAPK3—atherosclerosis	0.00721	0.011	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—HRH1—atherosclerosis	0.00714	0.0109	CbGpPWpGaD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—MMP9—atherosclerosis	0.00696	0.0106	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—UTS2—atherosclerosis	0.00686	0.0105	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—INS—atherosclerosis	0.00661	0.0101	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CX3CR1—atherosclerosis	0.00657	0.01	CbGpPWpGaD
Framycetin—Viral infection—Pravastatin—atherosclerosis	0.0065	0.0615	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—LEP—atherosclerosis	0.00649	0.0099	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CX3CL1—atherosclerosis	0.00645	0.00983	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—IGF1—atherosclerosis	0.00639	0.00975	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL2—atherosclerosis	0.00622	0.00949	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—atherosclerosis	0.00618	0.00942	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	0.00605	0.00923	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CASR—atherosclerosis	0.00555	0.00846	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—HRH1—atherosclerosis	0.00544	0.00829	CbGpPWpGaD
Framycetin—Swelling—Simvastatin—atherosclerosis	0.00535	0.0505	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL3—atherosclerosis	0.00526	0.00802	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL4—atherosclerosis	0.00516	0.00787	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CNR2—atherosclerosis	0.00516	0.00786	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CX3CR1—atherosclerosis	0.00515	0.00785	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	0.0051	0.00777	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL8—atherosclerosis	0.00492	0.0075	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—AKT1—atherosclerosis	0.00486	0.00741	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CG—atherosclerosis	0.00483	0.00737	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.00479	0.0073	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCR2—atherosclerosis	0.00475	0.00725	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—EDNRA—atherosclerosis	0.00475	0.00725	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—GHRL—atherosclerosis	0.00463	0.00706	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.0046	0.00701	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.00441	0.00673	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.00432	0.0066	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.0041	0.00625	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—KNG1—atherosclerosis	0.00407	0.0062	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—AGTR1—atherosclerosis	0.00404	0.00616	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CCR2—atherosclerosis	0.00401	0.00612	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL4—atherosclerosis	0.00393	0.00599	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—TGFB1—atherosclerosis	0.00383	0.00585	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.00372	0.00568	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.00372	0.00568	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—atherosclerosis	0.00362	0.00552	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.00353	0.00538	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	0.0035	0.00534	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—UTS2—atherosclerosis	0.0035	0.00534	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—KNG1—atherosclerosis	0.00343	0.00523	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—EDN1—atherosclerosis	0.00343	0.00523	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL5—atherosclerosis	0.0034	0.00518	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CX3CR1—atherosclerosis	0.00336	0.00512	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CASR—atherosclerosis	0.00336	0.00512	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CX3CL1—atherosclerosis	0.00329	0.00502	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—MMP9—atherosclerosis	0.00322	0.00491	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.00319	0.00486	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.00319	0.00486	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.00316	0.00483	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CNR2—atherosclerosis	0.00312	0.00476	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00311	0.00474	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HRH1—atherosclerosis	0.00307	0.00468	CbGpPWpGaD
Framycetin—Erythema—Ezetimibe—atherosclerosis	0.00298	0.0282	CcSEcCtD
Framycetin—Infection—Rosuvastatin—atherosclerosis	0.00291	0.0275	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CCL5—atherosclerosis	0.00287	0.00437	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—STAT3—atherosclerosis	0.00286	0.00436	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—AGT—atherosclerosis	0.00284	0.00434	CbGpPWpGaD
Framycetin—Erythema—Simvastatin—atherosclerosis	0.00284	0.0269	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—HRH1—atherosclerosis	0.00279	0.00425	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00273	0.00416	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00271	0.00413	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL3—atherosclerosis	0.00268	0.00409	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—F2—atherosclerosis	0.00263	0.00401	CbGpPWpGaD
Framycetin—Erythema—Niacin—atherosclerosis	0.00261	0.0247	CcSEcCtD
Framycetin—Anaphylactic shock—Lovastatin—atherosclerosis	0.00248	0.0234	CcSEcCtD
Framycetin—Infection—Lovastatin—atherosclerosis	0.00246	0.0233	CcSEcCtD
Framycetin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00243	0.023	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—EDNRA—atherosclerosis	0.00243	0.0037	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCR2—atherosclerosis	0.00243	0.0037	CbGpPWpGaD
Framycetin—Infection—Ezetimibe—atherosclerosis	0.00241	0.0228	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—AGT—atherosclerosis	0.0024	0.00366	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—GHRL—atherosclerosis	0.00237	0.00361	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL2—atherosclerosis	0.00234	0.00357	CbGpPWpGaD
Framycetin—Anaphylactic shock—Simvastatin—atherosclerosis	0.00232	0.0219	CcSEcCtD
Framycetin—Infection—Simvastatin—atherosclerosis	0.0023	0.0218	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.0023	0.0035	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00228	0.00348	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	0.00224	0.00341	CbGpPWpGaD
Framycetin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00215	0.0204	CcSEcCtD
Framycetin—Anaphylactic shock—Niacin—atherosclerosis	0.00213	0.0201	CcSEcCtD
Framycetin—Anaphylactic shock—Pravastatin—atherosclerosis	0.0021	0.0198	CcSEcCtD
Framycetin—Infection—Pravastatin—atherosclerosis	0.00208	0.0197	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—KNG1—atherosclerosis	0.00208	0.00317	CbGpPWpGaD
Framycetin—Pruritus—Rosuvastatin—atherosclerosis	0.00207	0.0196	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—AGTR1—atherosclerosis	0.00206	0.00315	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL4—atherosclerosis	0.00202	0.00308	CbGpPWpGaD
Framycetin—Diarrhoea—Rosuvastatin—atherosclerosis	0.002	0.0189	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—UTS2—atherosclerosis	0.00198	0.00302	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00191	0.00291	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CASR—atherosclerosis	0.0019	0.00289	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL8—atherosclerosis	0.00185	0.00282	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOA4—atherosclerosis	0.00185	0.00282	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—AKT1—atherosclerosis	0.00184	0.00281	CbGpPWpGaD
Framycetin—Hypersensitivity—Lovastatin—atherosclerosis	0.00183	0.0173	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—UTS2—atherosclerosis	0.0018	0.00274	CbGpPWpGaD
Framycetin—Hypersensitivity—Ezetimibe—atherosclerosis	0.00179	0.0169	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CNR2—atherosclerosis	0.00176	0.00269	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00176	0.00269	CbGpPWpGaD
Framycetin—Pruritus—Lovastatin—atherosclerosis	0.00175	0.0166	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—EDN1—atherosclerosis	0.00175	0.00267	CbGpPWpGaD
Framycetin—Nausea—Rosuvastatin—atherosclerosis	0.00174	0.0164	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCL5—atherosclerosis	0.00174	0.00265	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CX3CR1—atherosclerosis	0.00172	0.00263	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CASR—atherosclerosis	0.00172	0.00263	CbGpPWpGaD
Framycetin—Pruritus—Ezetimibe—atherosclerosis	0.00172	0.0163	CcSEcCtD
Framycetin—Hypersensitivity—Simvastatin—atherosclerosis	0.00171	0.0161	CcSEcCtD
Framycetin—Diarrhoea—Lovastatin—atherosclerosis	0.0017	0.016	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CX3CL1—atherosclerosis	0.00169	0.00258	CbGpPWpGaD
Framycetin—Diarrhoea—Ezetimibe—atherosclerosis	0.00166	0.0157	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—HRH1—atherosclerosis	0.00165	0.00251	CbGpPWpGaD
Framycetin—Pruritus—Simvastatin—atherosclerosis	0.00164	0.0155	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CNR2—atherosclerosis	0.0016	0.00244	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOA2—atherosclerosis	0.00159	0.00242	CbGpPWpGaD
Framycetin—Diarrhoea—Simvastatin—atherosclerosis	0.00159	0.015	CcSEcCtD
Framycetin—Vomiting—Lovastatin—atherosclerosis	0.00158	0.0149	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00157	0.0024	CbGpPWpGaD
Framycetin—Hypersensitivity—Niacin—atherosclerosis	0.00157	0.0148	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL8—atherosclerosis	0.00156	0.00238	CbGpPWpGaD
Framycetin—Vomiting—Ezetimibe—atherosclerosis	0.00155	0.0146	CcSEcCtD
Framycetin—Hypersensitivity—Pravastatin—atherosclerosis	0.00154	0.0146	CcSEcCtD
Framycetin—Pruritus—Niacin—atherosclerosis	0.00151	0.0142	CcSEcCtD
Framycetin—Pruritus—Pravastatin—atherosclerosis	0.00148	0.014	CcSEcCtD
Framycetin—Vomiting—Simvastatin—atherosclerosis	0.00147	0.0139	CcSEcCtD
Framycetin—Nausea—Lovastatin—atherosclerosis	0.00147	0.0139	CcSEcCtD
Framycetin—CXCR4—Disease—BGN—atherosclerosis	0.00147	0.00224	CbGpPWpGaD
Framycetin—Diarrhoea—Niacin—atherosclerosis	0.00146	0.0138	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—AGT—atherosclerosis	0.00145	0.00222	CbGpPWpGaD
Framycetin—Nausea—Ezetimibe—atherosclerosis	0.00144	0.0136	CcSEcCtD
Framycetin—Diarrhoea—Pravastatin—atherosclerosis	0.00143	0.0136	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCL3—atherosclerosis	0.00138	0.0021	CbGpPWpGaD
Framycetin—Nausea—Simvastatin—atherosclerosis	0.00138	0.013	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—EDNRA—atherosclerosis	0.00137	0.00209	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR2—atherosclerosis	0.00137	0.00209	CbGpPWpGaD
Framycetin—Vomiting—Niacin—atherosclerosis	0.00135	0.0128	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—F2—atherosclerosis	0.00134	0.00205	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GHRL—atherosclerosis	0.00134	0.00204	CbGpPWpGaD
Framycetin—Vomiting—Pravastatin—atherosclerosis	0.00133	0.0126	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—APOA4—atherosclerosis	0.00129	0.00197	CbGpPWpGaD
Framycetin—CXCR4—Disease—CST3—atherosclerosis	0.00128	0.00195	CbGpPWpGaD
Framycetin—Nausea—Niacin—atherosclerosis	0.00126	0.012	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCR2—atherosclerosis	0.00125	0.0019	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EDNRA—atherosclerosis	0.00125	0.0019	CbGpPWpGaD
Framycetin—Nausea—Pravastatin—atherosclerosis	0.00124	0.0118	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00124	0.00189	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GHRL—atherosclerosis	0.00121	0.00185	CbGpPWpGaD
Framycetin—CXCR4—Disease—NAMPT—atherosclerosis	0.00121	0.00185	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOC3—atherosclerosis	0.0012	0.00183	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL2—atherosclerosis	0.0012	0.00182	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL4—atherosclerosis	0.00119	0.00182	CbGpPWpGaD
Framycetin—CXCR4—Disease—LDLR—atherosclerosis	0.00119	0.00181	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—KNG1—atherosclerosis	0.00117	0.00179	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AGTR1—atherosclerosis	0.00117	0.00178	CbGpPWpGaD
Framycetin—CXCR4—Disease—HSPA1B—atherosclerosis	0.00115	0.00175	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOA2—atherosclerosis	0.00111	0.0017	CbGpPWpGaD
Framycetin—CXCR4—Disease—NCF1—atherosclerosis	0.00111	0.0017	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KNG1—atherosclerosis	0.00107	0.00163	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—UTS2—atherosclerosis	0.00106	0.00162	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AGTR1—atherosclerosis	0.00106	0.00162	CbGpPWpGaD
Framycetin—CXCR4—Disease—CYBA—atherosclerosis	0.00105	0.0016	CbGpPWpGaD
Framycetin—CXCR4—Disease—PARP1—atherosclerosis	0.00102	0.00156	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CX3CR1—atherosclerosis	0.00102	0.00155	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASR—atherosclerosis	0.00102	0.00155	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CX3CL1—atherosclerosis	0.000998	0.00152	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—EDN1—atherosclerosis	0.000989	0.00151	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCL5—atherosclerosis	0.000981	0.0015	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CNR2—atherosclerosis	0.000947	0.00144	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—atherosclerosis	0.000946	0.00144	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MMP3—atherosclerosis	0.000944	0.00144	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PRKCG—atherosclerosis	0.000933	0.00142	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EDN1—atherosclerosis	0.000898	0.00137	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL5—atherosclerosis	0.000891	0.00136	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCG—atherosclerosis	0.000847	0.00129	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VWF—atherosclerosis	0.000844	0.00129	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOC3—atherosclerosis	0.000838	0.00128	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LDLR—atherosclerosis	0.000833	0.00127	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AGT—atherosclerosis	0.000821	0.00125	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL3—atherosclerosis	0.000814	0.00124	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NCF1—atherosclerosis	0.000779	0.00119	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOB—atherosclerosis	0.00077	0.00117	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—F2—atherosclerosis	0.000759	0.00116	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AGT—atherosclerosis	0.000746	0.00114	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EDNRA—atherosclerosis	0.000736	0.00112	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR2—atherosclerosis	0.000736	0.00112	CbGpPWpGaD
Framycetin—CXCR4—Disease—LPL—atherosclerosis	0.000735	0.00112	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CYBA—atherosclerosis	0.000733	0.00112	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000726	0.00111	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLAT—atherosclerosis	0.000717	0.00109	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PARP1—atherosclerosis	0.000717	0.00109	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GHRL—atherosclerosis	0.000717	0.00109	CbGpPWpGaD
Framycetin—CXCR4—Disease—PRKCG—atherosclerosis	0.000715	0.00109	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—F2—atherosclerosis	0.000689	0.00105	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTHFR—atherosclerosis	0.000662	0.00101	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CG—atherosclerosis	0.000659	0.00101	CbGpPWpGaD
Framycetin—CXCR4—Disease—PDGFB—atherosclerosis	0.000644	0.000982	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KNG1—atherosclerosis	0.00063	0.00096	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGTR1—atherosclerosis	0.000626	0.000954	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOE—atherosclerosis	0.000616	0.00094	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL2—atherosclerosis	0.000614	0.000936	CbGpPWpGaD
Framycetin—CXCR4—Disease—CAV1—atherosclerosis	0.000611	0.000931	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLG—atherosclerosis	0.00061	0.00093	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOA1—atherosclerosis	0.000609	0.000929	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SOCS3—atherosclerosis	0.000578	0.000881	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS2—atherosclerosis	0.000574	0.000876	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP3—atherosclerosis	0.000558	0.000851	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF2—atherosclerosis	0.000555	0.000847	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOB—atherosclerosis	0.000539	0.000822	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—atherosclerosis	0.000535	0.000815	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EDN1—atherosclerosis	0.000531	0.000809	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL5—atherosclerosis	0.000526	0.000803	CbGpPWpGaD
Framycetin—CXCR4—Disease—INS—atherosclerosis	0.000526	0.000803	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LPL—atherosclerosis	0.000515	0.000785	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCG—atherosclerosis	0.000501	0.000763	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SPP1—atherosclerosis	0.000488	0.000744	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—atherosclerosis	0.000485	0.00074	CbGpPWpGaD
Framycetin—CXCR4—Disease—SERPINE1—atherosclerosis	0.000484	0.000737	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS3—atherosclerosis	0.000462	0.000704	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDGFB—atherosclerosis	0.000451	0.000688	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGT—atherosclerosis	0.00044	0.000672	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOE—atherosclerosis	0.000432	0.000658	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LEP—atherosclerosis	0.000432	0.000658	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CAV1—atherosclerosis	0.000428	0.000652	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOA1—atherosclerosis	0.000427	0.000651	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—atherosclerosis	0.000422	0.000644	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ESR1—atherosclerosis	0.000412	0.000628	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—F2—atherosclerosis	0.000407	0.000621	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CG—atherosclerosis	0.000389	0.000594	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK3—atherosclerosis	0.000373	0.000569	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—INS—atherosclerosis	0.000369	0.000562	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL2—atherosclerosis	0.000363	0.000553	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1—atherosclerosis	0.000357	0.000544	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SERPINE1—atherosclerosis	0.000339	0.000516	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT3—atherosclerosis	0.000329	0.000502	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOS3—atherosclerosis	0.000323	0.000493	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK3—atherosclerosis	0.000315	0.00048	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFB1—atherosclerosis	0.000305	0.000466	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—atherosclerosis	0.000287	0.000437	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—atherosclerosis	0.000277	0.000422	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—atherosclerosis	0.000273	0.000416	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—atherosclerosis	0.000259	0.000396	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NFKB1—atherosclerosis	0.000257	0.000391	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK8—atherosclerosis	0.000252	0.000385	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—atherosclerosis	0.000252	0.000384	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—atherosclerosis	0.000233	0.000355	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT3—atherosclerosis	0.000231	0.000352	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—atherosclerosis	0.00023	0.000351	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK3—atherosclerosis	0.00022	0.000336	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFB1—atherosclerosis	0.000214	0.000326	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—atherosclerosis	0.000212	0.000324	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—atherosclerosis	0.000161	0.000246	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—atherosclerosis	0.000149	0.000227	CbGpPWpGaD
